Degnan Chris 4
4 · Galera Therapeutics, Inc. · Filed Jan 28, 2021
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-26+82,500→ 82,500 totalExercise: $11.99Exp: 2031-01-25→ Common Stock (82,500 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 26, 2021.